![]() |
市场调查报告书
商品编码
1871532
弹性成像诊断市场规模、份额和成长分析(按技术、应用、最终用户和地区划分)—2025-2032年产业预测Elastography Imaging Market Size, Share, and Growth Analysis, By Technology (Ultrasound Elastography, Magnetic Resonance Elastography ), By Application (General Imaging / Radiology, Hepatology ), By End-User, By Region - Industry Forecast 2025-2032 |
||||||
全球弹性成像市场预计在 2023 年达到 27 亿美元,从 2024 年的 29.1 亿美元成长到 2032 年的 53.1 亿美元,在预测期(2025-2032 年)内复合年增长率为 7.8%。
由于对非侵入性诊断技术的需求不断增长,以及慢性肝病和乳癌发生率的上升,全球弹性成像市场正经历显着成长。超音波和磁振造影(MRI)弹性成像技术的进步也推动了这一成长。公众对疾病早期检测意识的提高,以及政府的积极倡议,预计将进一步推动市场成长。此外,弹性成像技术在发展中地区的快速普及,以及携带式成像技术的创新,正在提高其可及性。主要市场参与者正在加大研发投入,以提高成像精度并拓展其临床应用。这些因素共同作用,预计将扩大弹性成像在诊断成像领域的应用范围。
全球弹性成像诊断市场驱动因素
代谢功能障碍相关脂肪肝的日益增多显着推动了肝臟硬度常规测量的普及。二维剪切波弹性成像技术展现出极高的准确性,有助于有效评估肝臟状况。超音波引导衰减参数与剪切波资料的结合,使得患者调查方法日益精细化,从而提高了对危及生命事件的风险评估。在乳房健康管理领域,弹性成像已成为緻密乳房筛检的关键手段,能够以高灵敏度和特异性成功识别恶性微钙化灶。弹性成像在肿瘤学领域的应用日益广泛,也使其在放射科的应用更加普及,巩固了其作为传统切片检查之外的首选非侵入性检查方法的地位。
全球弹性成像诊断市场限制因素
全球弹性成像市场面临许多重大障碍,限制了其成长潜力。例如,医疗机构对某些疾病(如进行性肝纤维化)的报销限制,阻碍了弹性成像技术在筛检的广泛应用。此外,一些保险公司将弹性成像技术在肝臟相关应用之外的领域归类为研究性技术,这使得心臟病学和肌肉骨骼疾病等领域的报销工作更加复杂。行政方面的挑战,包括事先核准要求,进一步阻碍了医疗机构将弹性成像技术纳入常规诊疗实践。心臟弹性成像技术缺乏标准化的支付模式,阻碍了指南的发展和推广,而要真正扩大其覆盖范围,则需要进行全面的疗效研究,以证明其成本效益。
全球弹性成像诊断市场趋势
全球弹性成像市场正经历一个显着的趋势:随着人工智慧技术的快速整合,诊断准确性和工作流程效率显着提升。人工智慧驱动的弹性成像解决方案透过自动化组织硬度分析,最大限度地减少操作者之间的解读差异,从而推动医疗保健领域的变革。由于这些智慧系统能够进行符合临床标准的预测性分析,主要产业参与者正积极部署先进的弹性成像系统,以支援即时决策。这项创新不仅缩短了检查时间,还增强了疾病的早期检测能力,尤其是在乳癌和非酒精性脂肪性肝病(NAFLD)等关键健康问题方面,使弹性成像技术处于现代诊断成像技术的前沿地位。
Global Elastography Imaging Market size was valued at USD 2.7 billion in 2023 and is poised to grow from USD 2.91 billion in 2024 to USD 5.31 billion by 2032, growing at a CAGR of 7.8% during the forecast period (2025-2032).
The global elastography imaging market is experiencing significant growth driven by the rising demand for non-invasive diagnostic methods and increasing prevalence of chronic liver disease and breast cancer. Advances in elastography techniques within ultrasound and MRI modalities are also contributing to this expansion. Heightened public awareness regarding early disease detection, alongside favorable government initiatives, is expected to further stimulate market growth. Additionally, the swift adoption of elastography in developing regions, coupled with innovations in portable imaging technologies, is enhancing accessibility. Key market players are investing in research and development to improve imaging accuracy and increase clinical applications. Collectively, these factors are set to elevate the overall utilization of elastography in diagnostic imaging.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Elastography Imaging market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Elastography Imaging Market Segments Analysis
Global Elastography Imaging Market is segmented by Technology, Application, End-User and region. Based on Technology, the market is segmented into Ultrasound Elastography and Magnetic Resonance Elastography (MRE). Based on Application, the market is segmented into General Imaging / Radiology, Hepatology (Liver / Fibrosis), Breast Imaging, Cardiology, Orthopedic & Musculoskeletal and Urology / Vascular / Others. Based on End-User, the market is segmented into Hospitals, Diagnostic Imaging Centres and Ambulatory Surgical Centres (ASCs). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Elastography Imaging Market
The increasing prevalence of metabolic dysfunction-associated steatotic liver disease is significantly boosting the adoption of routine liver stiffness measurements. Two-dimensional shear-wave elastography has demonstrated impressive accuracy levels, helping to effectively assess liver conditions. The methodology for stratifying patients is being enhanced through the integration of ultrasound-guided attenuation parameters alongside shear-wave data, thus improving risk assessment for life-threatening events. In the realm of breast health, elastography is becoming pivotal for dense-breast screening, successfully identifying malignant microcalcifications with high sensitivity and specificity. The growing use of elastography in oncology is leading to more frequent equipment utilization in radiology suites, reinforcing its status as a preferred non-invasive alternative to traditional biopsy methods.
Restraints in the Global Elastography Imaging Market
The Global Elastography Imaging market faces several significant hurdles that restrict its growth potential. Coverage limitations imposed by healthcare providers for specific conditions, such as advanced hepatic fibrosis, hinder the broader adoption of elastography for screening applications. Additionally, certain insurers categorize elastography as investigational outside of liver-related uses, which complicates reimbursement efforts in fields like cardiology and musculoskeletal care. Administrative challenges, including prior-authorization requirements, further discourage healthcare practitioners from integrating elastography into routine practice. The lack of standardized payment models for cardiac elastography creates a barrier to guideline recommendations, while meaningful expansions in coverage are contingent on comprehensive outcome studies illustrating cost-effectiveness.
Market Trends of the Global Elastography Imaging Market
The Global Elastography Imaging market is witnessing a robust trend towards the accelerated integration of artificial intelligence technologies, enhancing diagnostic precision and streamlining workflows. AI-driven elastography solutions are transforming the landscape by automating tissue stiffness analysis, thereby minimizing interpretation discrepancies among operators. As these intelligent systems facilitate predictive analytics aligned with clinical standards, major industry players are proactively launching advanced elastography systems designed for real-time decision-making. This innovation not only shortens examination durations but also bolsters early disease detection capabilities, particularly in critical health issues such as breast cancer and non-alcoholic fatty liver disease (NAFLD), positioning elastography at the forefront of modern diagnostic imaging.